UCB SA (OTCMKTS:UCBJY) to Issue $0.46 Dividend

UCB SA (OTCMKTS:UCBJYGet Free Report) declared a dividend on Friday, April 19th, investing.com reports. Investors of record on Monday, April 29th will be given a dividend of 0.4574 per share on Wednesday, May 15th. This represents a yield of 0.71%. The ex-dividend date is Friday, April 26th.

UCB Trading Down 0.7 %

OTCMKTS:UCBJY opened at $64.79 on Thursday. UCB has a 12-month low of $34.85 and a 12-month high of $65.55. The stock has a fifty day moving average price of $59.07 and a 200 day moving average price of $47.78.

About UCB

(Get Free Report)

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies.

Further Reading

Receive News & Ratings for UCB Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UCB and related companies with MarketBeat.com's FREE daily email newsletter.